-
2023-509396-16-00
5
2021-11-08
Metastatic Castration-Resistant Prostate Cancer
-
2023-507342-84-00
5
2021-10-26
Bladder Cancer
-
2023-503990-39-00
5
2021-09-30
Estrogen Receptor-Positive, HER-2 negative Advanced Breast Cancer
-
2023-506752-24-00
5
2021-08-05
Locally recurrent inoperable or metastatic HR+/HER2- breast cancer, wh
-
2023-508308-40-00
5
2021-07-30
Metastatic (stage IV) squamous or nonsquamous non-small cell lung canc
-
2022-502100-70-00
10
2021-06-23
Participants with Microsatellite Instability-High (MSI-H) or Mismatch
-
2023-504997-39-00
5
2021-06-14
Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2
-
2022-502122-41-00
5
2021-05-11
Clear cell renal cancer
-
2023-503995-26-00
5
2021-05-11
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
-
2023-505615-21-00
5
2021-04-28
Muscle Invasive Bladder Cancer
-
2024-516653-44-00
5
2020-11-30
HER2-Low, Hormone Receptor Positive Breast Cancer which has Progressed
-
2023-505852-23-00
5
2020-11-12
High risk recurrent prostate cancer previously treated with radical pr
-
2023-504998-20-00
5
2020-09-18
Metastatic Hormone-sensitive Prostate Cancer Characterised by PTEN def
-
2023-505830-89-00
6
2020-08-05
metastatic castrate resistant prostate cancer (mCRPC)
-
2023-503500-87-00
11
2020-03-17
Muscle Invasive Bladder Cancer
-
2023-506153-38-00
5
2019-07-11
High-risk localized or locally advanced prostate cancer
-
2023-510015-19-00
5
2019-02-11
Patients with histologically or cytologically documented muscle-invasi
-
2024-510976-19-00
5
2018-11-30
Patients with Unresectable Locally Advanced or Metastatic Urothelial C
-
2023-505341-23-00
5
2018-07-27
Non-muscle invasive bladder cancer
-
2023-504942-75-01
5
2024-08-22
Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis with or witho
-
2022-502982-49-00
4
2024-07-15
Metastatic Castration-Resistant Prostate Cancer
-
2023-508013-16-00
5
2024-02-26
Birch pollen induced allergic rhinitis or rhinoconjunctivitis
-
2022-501078-20-00
4
2023-05-15
Metastatic Castration-resistant Prostate Cancer
-
2023-505457-40-00
5
2022-02-02
Previously Untreated Advanced Gastric or Gastroesophageal Junction
Can